
Razadyne For Alzheimer’s: Improves Thinking, Lifespan
MEDICATION: Razadyne (generic galantamine) is an FDA-Approved daffodil extract for Alzheimer’s. Learn how it significantly lowered mortality & eased cognitive decline.

MEDICATION: Razadyne (generic galantamine) is an FDA-Approved daffodil extract for Alzheimer’s. Learn how it significantly lowered mortality & eased cognitive decline.

Biogen reprioritize resources allocated to ADUHELM® to advance LEQEMBI®.

MEDICATION VIDEO: Aricept® (generic DONEPEZIL) is the world’s most popular drug for Early-stage Alzheimer’s. Does it help in Advanced-stage Alzheimer’s?

CLINICAL INERTIA is when it’s much easier to start someone on a medication, and keep them on, than to take them off. Find out why most advanced dementia patients receive too many expensive, questionable medications.

At long last, we finally have a disease-modifying drug for Alzheimer’s. The FDA recently approved a new drug that promises to slow the progression of the disease. Only five Alzheimer’s treatments have been approved by the FDA up until a decade ago, and this is only the second to address the progression of the disease.

FDA-approved ADLARITY is the once-weekly donepezil patch. See how it compares to donepezil / Aricept / Ebixa tablets for Alzheimer’s.

Swedish researchers find that cholinesterase inhibitors provide cognitive benefits and reduce mortality for up to five years after an Alzheimer’s diagnosis. One medication significantly reduced the risk of developing severe dementia.

Now, a third new Alzheimer’s drug expected to be approved by the Food and Drug Administration (FDA),. The field of new drugs is beginning to show progress in the fight to slow the disease.

First drug to modestly slow Alzheimer’s cognitive decline, based on 1,800 patients.

The FDA Advisory Committee’s endorsement of Leqembi paves way for traditional approval, ushers in a new era for Alzheimer’s

A personal diary of a daughter with a medical background that chronicles her journey while caring for her father with Alzheimer’s, and gives the reader the gift of both perspectives, that of a loving daughter and the trained professional.

Scientists say restoring a brain protein, not removing amyloid plaques, should be the target of Alzheimer’s dementia therapies. The researchers said treatment might lie in normalizing the levels of a specific brain protein.

Did you know? Intellectual abilities are increased in the brain by an average 300% in most people ages 60-80.

The brush strokes are precise, the colors vibrant. See a Colorado art program help patients rise above dementia, while the paintings raise money for The Alzheimer’s Association.

The protein BDNF builds synapses in the human brain, nurturing brain cells and fighting off dementia. While there is no artificial way of boosting it, social and cognitive activity can.

People may not have easy access to sophisticated, expensive dementia tests. A simple test from Einstein Medicine uses a stopwatch and a few questions to determine one’s risk of dementia. The potential payoff could be tremendous for individuals, their families and society.

Ketone-rich diets increase the SIRT3 protein that protects neurons from death during the progression of Alzheimer’s disease. But how does it work? Find out more.
No spam, only news and updates.


